MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $549,509 | +20.5% | 12,615 | -0.1% | 0.01% | +22.2% |
| Q2 2023 | $456,069 | -2.8% | 12,623 | +0.1% | 0.01% | -18.2% |
| Q1 2023 | $469,026 | -17.9% | 12,615 | 0.0% | 0.01% | -31.2% |
| Q4 2022 | $571,586 | -35.1% | 12,615 | -0.0% | 0.02% | -33.3% |
| Q3 2022 | $881,000 | +4.0% | 12,621 | +0.0% | 0.02% | -7.7% |
| Q2 2022 | $847,000 | -18.4% | 12,615 | -0.1% | 0.03% | +4.0% |
| Q1 2022 | $1,038,000 | -43.9% | 12,624 | +0.1% | 0.02% | -41.9% |
| Q4 2021 | $1,850,000 | -18.6% | 12,615 | -1.8% | 0.04% | -28.3% |
| Q3 2021 | $2,273,000 | – | 12,849 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |